|
|
Zimmer Biomet Holdings Inc (ZBH) |
|
|
|
ZBH's EPS from Cont. Operations Growth by Quarter and Year
Zimmer Biomet Holdings Inc 's EPS from Cont. Operations results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
EPS from Cont. Operations Growth Y/Y▼
|
EPS from Cont. Operations Growth Y/Y▼
|
ZBH EPS from Cont. Operations (in $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
IV Quarter |
December |
-
|
-0.62
|
-0.40
|
1.61
|
III Quarter |
September |
0.78
|
0.92
|
0.70
|
1.17
|
II Quarter |
June |
1.00
|
0.73
|
0.68
|
-1.00
|
I Quarter |
March |
1.11
|
0.35
|
0.95
|
-2.46
|
FY |
|
2.89
|
1.38
|
1.93
|
-0.68
|
ZBH EPS from Cont. Operations third quarter 2023 Y/Y Growth Comment |
Zimmer Biomet Holdings Inc reported decline in EPS from Cont. Operations in the third quarter 2023 by -15.22% to $ 0.78 , from the same quarter in 2022. The contraction in the third quarter 2023 Zimmer Biomet Holdings Inc 's EPS from Cont. Operations compares unfavorably to the Company's average EPS from Cont. Operations doubling of 131.09%.
Looking into third quarter 2023 results within Medical Equipment & Supplies industry 31 other companies have achieved higher EPS from Cont. Operations growth. While Zimmer Biomet Holdings Inc ' s EPS from Cont. Operations fall of -15.22% ranks overall at the positon no. 1182 in the third quarter 2023.
|
ZBH EPS from Cont. Operations ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
- |
- |
- |
3.21 % |
III Quarter |
September |
-15.22 % |
31.43 % |
-40.17 % |
-44.29 % |
II Quarter |
June |
36.99 % |
7.35 % |
- |
- |
I Quarter |
March |
217.14 % |
-63.16 % |
- |
- |
FY |
|
- |
-28.5 % |
- |
- |
ZBH EPS from Cont. Operations (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
- |
- |
- |
37.61 % |
III Quarter |
September |
-22 % |
26.03 % |
2.94 % |
- |
II Quarter |
June |
-9.91 % |
108.57 % |
-28.42 % |
- |
I Quarter |
March |
- |
- |
-40.99 % |
- |
FY (Year on Year) |
|
- |
-28.5 % |
- |
- |
EPS from Cont. Operations Y/Y Growth Statistics |
High |
Average |
Low |
1581.7 % |
131.09 % |
-63.16 % |
(Dec 31 2017) |
|
(Mar 31 2022) |
|
EPS from Cont. Operations Y/Y Growth Statistics |
High |
Average |
Low |
1581.7 % |
131.09 % |
-63.16 % |
(Dec 31 2017) |
|
(Mar 31 2022) |
|
EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Zimmer Biomet Holdings Inc 's Q/Q EPS from Cont. Operations Growth
EPS from Cont. Operations Q/Q Growth Statistics |
High |
Average |
Low |
1141.63 % |
76.17 % |
-85.86 % |
(Dec 31 2017) |
|
|
ZBH's III. Quarter Q/Q EPS from Cont. Operations Comment |
In the III. Quarter 2023 Zimmer Biomet Holdings Inc realized fall in EPS from Cont. Operations from the previous quarter by -22% to $ 0.78 , from $ 1.00 released in the previous quarter.
Albeit periodic circumstance normally fuel III. Quarter 2023 EPS from Cont. Operations, that plainly has not been sufficient to rescue Zimmer Biomet Holdings Inc 's III. Quarter 2023 outcome, Joshua Smith, a business contributor wrote.
Within Medical Equipment & Supplies industry 25 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Zimmer Biomet Holdings Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 948. |
|
|
EPS from Cont. Operations Q/Q Growth Statistics |
High |
Average |
Low |
1141.63 % |
76.17 % |
-85.86 % |
(Dec 31 2017) |
|
|
ZBH's III. Quarter Q/Q EPS from Cont. Operations Comment |
In the III. Quarter 2023 Zimmer Biomet Holdings Inc disclosed fall in EPS from Cont. Operations from the previous quarter by -22% to $ 0.78 , from $ 1.00 declared a quarter before.
Those cyclical circumstance were not able to rescue the III. Quarter for the Zimmer Biomet Holdings Inc , Joshua Smith, a business contributor wrote, he voiced some skepticism conserning ZBH's outlook, he identified further challenges down the road for Zimmer Biomet Holdings Inc .
Within Medical Equipment & Supplies industry 25 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Zimmer Biomet Holdings Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 948. |
|
Zimmer Biomet Holdings Inc 's 12 Months EPS from Cont. Operations Growth Year on Year
EPS from Cont. Operations TTM Growth |
12 Months Ending (Sep 30 2023) |
12 Months Ending (Jun 30 2023) |
12 Months Ending (Mar 31 2023) |
12 Months Ending (Dec 31 2022) |
12 Months Ending (Sep 30 2022) |
Cumulative EPS from Cont. Operations 12 Months Ending |
$ 2.27 |
$ 2.41 |
$ 2.14 |
$ 1.38 |
$ 1.60 |
Y / Y EPS from Cont. Operations Growth (TTM) |
41.92 % |
74.73 % |
60.98 % |
-28.53 % |
-59.41 % |
Year on Year EPS from Cont. Operations Growth Overall
Ranking |
# 1273 |
# 662 |
# 517 |
# 1705 |
# 1041 |
Seqeuential EPS from Cont. Operations Change (TTM) |
-5.81 % |
12.63 % |
55.15 % |
-13.77 % |
15.96 % |
Seq. EPS from Cont. Operations Growth (TTM) Overall
Ranking |
# 415 |
# 346 |
# 464 |
# 1703 |
# 341 |
Cumulative EPS from Cont. Operations growth
Comment |
With the quarterly EPS from Cont. Operations reported in the Sep 30 2023 period, Zimmer Biomet Holdings Inc 's cumulative twelve months EPS from Cont. Operations were $ 2 , company would post below average annual EPS from Cont. Operations growth of 15.96% year on year, if the fiscal year would end at Sep 30 2023. A slow-down in the Zimmer Biomet Holdings Inc 's EPS from Cont. Operations growth from the 1% growth in Jun 30 2023.
In the Healthcare sector 80 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 662 to 1273. |
EPS from Cont. Operations TTM Q/Q Growth Statistics |
High |
Average |
Low |
2131.01 % |
144.31 % |
-121.18 % |
|
|
|
|
|
EPS from Cont. Operations TTM Y/Y Growth Statistics |
High |
Average |
Low |
2131.01 % |
144.31 % |
-121.18 % |
|
|
|
EPS from Cont. Operations TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 9 |
Sector |
# 26 |
S&P 500 |
# 415 |
|
Cumulative EPS from Cont. Operations growth
Comment |
With the quarterly EPS from Cont. Operations reported in the Sep 30 2023 period, Zimmer Biomet Holdings Inc 's cumulative twelve months EPS from Cont. Operations were $ 2 , company would post below average annual EPS from Cont. Operations growth of -121.18% year on year, if the fiscal year would end at Sep 30 2023. A slow-down in the Zimmer Biomet Holdings Inc 's EPS from Cont. Operations growth from the 1% growth in Jun 30 2023.
In the Healthcare sector 80 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 662 to 1273. |
EPS from Cont. Operations TTM Q/Q Growth Statistics |
High |
Average |
Low |
2131.01 % |
144.31 % |
-121.18 % |
|
|
|
EPS from Cont. Operations TTM Y/Y Growth Statistics |
High |
Average |
Low |
2131.01 % |
144.31 % |
-121.18 % |
|
|
|
EPS from Cont. Operations TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 9 |
Sector |
# 26 |
S&P 500 |
# 415 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com